- Citations, last 5 years
- 110
- Works, last 5 years
- 14
- h-index
- 21
- Scientists listed
- 4
- Grants since 2016
- 5
Grants received
2020–2023 · research · R44
Thermostabilized Subunit Glycoprotein Vaccine Platform: Immune Characterization of an Emulsified Adjuvant with SARS-CoV-2 Spike Protein and EBOV GP
Oreola Donini · Soligenix (United States) · funded by National Institutes of Health
2020–2022 · research · R44
Thermostabilized Subunit Glycoprotein Vaccine Platform: Immune Characterization of an Emulsified Adjuvant with SARS-CoV-2 Spike Protein and EBOV GP
Oreola Donini · Soligenix (United States) · funded by National Institutes of Health
2019–2020 · research · R43
"Dusquetide for the treatment of oral mucositis in the pediatric population"
Oreola Donini · Soligenix (United States) · funded by National Institutes of Health
2017–2019 · research · R44
Phase 3 Study of SGX301 and Fluorescent Light for Cutaneous T Cell Lymphoma
Richard Conrad Straube · Soligenix (United States) · funded by National Institutes of Health
2017–2020 · research · R44
Phase 3 Study of SGX301 and Fluorescent Light for Cutaneous T Cell Lymphoma
Richard Conrad Straube · Soligenix (United States) · funded by National Institutes of Health
